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Endocytosis takes occludin for a ride
T
he lining of the small intestine 
locks out bacteria and toxins 
while soaking up nutrients and 
water. By observing intestinal cells of live 
mice through the microscope, Marchiando 
et al. (1) reveal the mechanism that regu-
lates this barrier. The study shows the 
importance of the tight junction protein 
occludin for the process and identifi  es the 
endocytic route that removes occludin to 
adjust permeability.
An intestinal leak is a potential disas-
ter. “The gut is a cesspool,” says senior 
author Jerry Turner. “You will die from an 
overwhelming infection if your barrier 
fails.” The epithelial cells that line the in-
testine establish the barrier. Adherens 
junctions fasten adjacent cells in the lin-
ing together (2), but tight junctions seal 
the gaps, functioning like a gasket be-
tween cells. Unlike a rubber gasket, a 
tight junction can alter its permeability. 
Tumor necrosis factor (TNF), which un-
derlies some symptoms of Crohn’s dis-
ease, spurs the tight junctions to relax and 
allows water to leak into the intestine, re-
sulting in diarrhea (3). The junction ap-
pears to remain intact, and the structural 
changes that produce this altered perme-
ability have remained elusive.
The researchers fi  rst ruled out one group 
of tight junction proteins, the claudins, which 
are crucial for maintaining the intestinal bar-
rier. Turner’s group then turned to occludin. 
Although the protein isn’t 
essential for junction forma-
tion, a previous study from 
Turner’s lab (3) indicated 
that when TNF induces in-
testinal  leakiness, occludin 
exits the membrane of the 
epithelial cells. However, 
researchers hadn’t resolved 
whether occludin relocation 
alters the lining’s permeabil-
ity or whether it is a marker of other events.
Marchiando et al. tracked occludin dy-
namics in transgenic mice that produced a 
GFP-tagged version of the protein. After 
anesthetizing an animal, the researchers 
cut open the abdomen, popped out a loop 
of small intestine, and sliced it open. Dur-
ing the procedure the organ retains normal 
blood fl  ow and nerve connections. With 
the animal resting on a confocal micro-
scope stage, the researchers could lay the 
intestinal lining over a cover slip and watch 
how occludin’s location shifted after a dose 
of TNF. There was no visible effect until 
nearly 90 minutes after the cytokine’s 
injection. Then occludins in the junction 
began to clump. Shortly afterward, vesicles 
containing the protein started streaming 
away from the cell membrane. Occludin 
“looked like it was internalizing directly 
from tight junctions,” says Turner.
The researchers also took advantage of 
the transgenic mice to nail down occludin’s 
role in setting the barrier’s 
permeability. The engi-
neered mice manufacture 
almost twice as much occlu-
din as normal, and their tight 
junctions appear to be extra 
tight. Unlike in normal mice, 
TNF did not cause diarrhea 
in the transgenic animals.
Marchiando et al. then 
asked what abducts occlu-
din and spirits it to the cell interior. Earlier 
in vitro studies by Turner’s group and by 
other scientists (4, 5) identifi  ed  three 
suspects. The team found that blocking 
macropinocytosis, a method by which cells 
engulf fl  uid, didn’t affect the number of 
vesicles harboring occludin, casting doubt 
on one potential mechanism. A second 
possibility—removal by clathrin-coated 
pits—also clashed with the evidence. A 
drug that prevents endocytosis via these 
pits had no effect on occludin endocytosis. 
Instead, the team’s experiments pointed to 
a role for cholesterol-rich membrane rafts 
that are similar to caveolae. For instance, 
occludin often internalized with caveolin-1, 
a marker of this endocytic route. And in 
mice lacking caveolin-1, TNF doesn’t spur 
endocytosis of occludin or diarrhea.
“The data show that even though it is 
not required for basal function, occludin 
does play a really important role in tight 
junction regulation,” says Turner. Removal 
of the protein seems to make the junctions 
more porous. This increased permeability 
can be detrimental, as in Crohn’s disease. 
But it could also be helpful, possibly allow-
ing cells to quickly absorb a surge of 
nutrients in the intestine. What researchers 
now need to fi  gure out, Turner says, is 
how addition and removal of occludin 
change tight junction structure.
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Amanda Marchiando (second from right, front row), Jerry Turner (far left, front row), and 
colleagues are interested in how the intestinal lining ﬁ  ne-tunes its permeability by moving 
the tight junction protein occludin. In this cross-section of intestinal villi, occludin (green) 
concentrates at tight junctions.
“The gut is a 
cesspool. You 
will die from an 
overwhelming 
infection if your 
barrier fails.”
Researchers show how cells remove a tight junction protein to tweak small intestine permeability.
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